Karsten A. Pilones
Genmab (United States) · 99 works · 2,696 citations · h-index 19
Top works
- TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity
- Suppressing T cell motility induced by anti–CTLA-4 monotherapy improves antitumor effects
- In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment
- TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo
- Invariant Natural Killer T Cells Regulate Breast Cancer Response to Radiation and CTLA-4 Blockade
- Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells
- Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs
- Combination of Radiotherapy and Immune Checkpoint Inhibitors
- Barriers to Radiation-Induced In Situ Tumor Vaccination
- Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes
- The Optimal Partnership of Radiation and Immunotherapy: from Preclinical Studies to Clinical Translation
- Exploiting the stress response to radiation to sensitize poorly immunogenic tumors to anti-CTLA-4 treatment
- Radiotherapy induces responses of lung cancer to CTLA-4 blockade
- Abstract 536: NBTXR3 potentiate cancer-cell intrinsic interferon beta response to radiotherapy
- Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses
- Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade
- Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts
- Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
- CD8+ T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
- Melanoma and immunotherapy bridge 2015